ILC2s-Bipartisan politicians in cancer Review


Authors: Zebboudj, A.; Amisaki, M.; Balachandran, V. P.
Review Title: ILC2s-Bipartisan politicians in cancer
Abstract: Group 2 innate lymphoid cells (ILC2s) are lymphocytes that both promote and suppress antitumor immunity. Jou and colleagues now report in colorectal tumorigenesis that the cytokine interleukin-25 activates ILC2s to induce myeloid cells that suppress antitumor immunity.
Keywords: neoplasm; neoplasms; cytokine; cytokines; innate immunity; immunity, innate; lymphocyte; lymphocytes; humans; human
Journal Title: Science Immunology
Volume: 7
Issue: 72
ISSN: 2470-9468
Publisher: Amer Assoc Advancement Science  
Date Published: 2022-06-01
Start Page: eabq2791
Language: English
DOI: 10.1126/sciimmunol.abq2791
PUBMED: 35658014
PROVIDER: scopus
PMCID: PMC9207974
DOI/URL:
Notes: Review -- Export Date: 1 July 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Masataka Amisaki
    10 Amisaki